Interim Results for the 6 months ended 31 October 2021
by admin | Jan 26, 2022 | Regulatory News
Recent Posts
- Scancell to Present at the H.C. Wainwright 28th Annual Global Investment Conference
- H.C. Wainwright 28th Annual Global Investment Conference
- Scancell Receives UK MHRA Clinical Trial Authorization for Phase 3 Registrational Trial of iSCIB1+ in Advanced Melanoma
- Strategic transactions to unlock longer-term value
- Scancell and Neuphoria Therapeutics Announce Merger Agreement and Financing
Recent Comments
No comments to show.